SCHEMBL1638313

SCHEMBL1638313

CC(C)(C)c1cccc(-c2cccc(C(O)c3ccccn3)c2)c1OCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FEN1 P39748 1/20 0.39
ALOX5AP P20292 1/20 0.37
ALOX5 P09917 1/20 0.37
CTSA P10619 3/20 0.37
FFAR1 O14842 2/20 0.37
BRD4 O60885 1/20 0.37
GRM5 P41594 1/20 0.36
PTGER1 P34995 5/20 0.35
IDH1 O75874 3/20 0.35
PTGER4 P35408 2/20 0.35
PTGER3 P43115 2/20 0.35
PTGER2 P43116 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12646953 0.86 IDH1 (0.39) ALOX5CTSABRD4IDH1
SCHEMBL1636835 0.80 FFAR1 (0.41) LMNAHPGDALOX15TSHRMAPK1
SCHEMBL27877465 0.79 PTGER1 (0.43) FEN1ALOX5CTSAFFAR1PTGER1
SCHEMBL1638665 0.76 MAPT (0.39) LMNAHPGDALOX15TSHRMAPK1
SCHEMBL1637994 0.76 PTGER1 (0.40) HPGDFEN1ALOX5APFFAR1GRM5
SCHEMBL1636908 0.76 PTGER1 (0.45) LMNAHPGDFFAR1GRM5PTGER1
SCHEMBL1637811 0.73 MAOB (0.54) PTGER1PTGER4PTGER3PTGER2
SCHEMBL1759295 0.73 FEN1 (0.42) FEN1ALOX5APFFAR1GRM5PTGER1
SCHEMBL1643036 0.72 FEN1 (0.47) MAPK1FEN1ALOX5APFFAR1BRD4
SCHEMBL12076146 0.72 MGAM (0.41) FEN1ALOX5APFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541522-B2 Catalyst compounds and use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-09-24 US disclosed
US-8541522-B2 Catalyst compounds and use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-09-24 US disclosed
US-20110098429-A1 Catalyst Compounds and Use Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2011-04-28 US disclosed
US-20110098429-A1 Catalyst Compounds and Use Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098429-A1 Catalyst Compounds and Use Thereof ALOX12, THEM6, ALOX15 LMNA 4232/4885HPGD 835/4885ALOX15 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.